To investigate the effect of stable autophagy inhibition in RAS-mutated human cancer cells, we used CRISPR/Cas9 to ablate ATG5 expression in A549 lung adenocarcinoma cells (Fig. 1a, b). This evidence concerns the gene ATG5 and cancer.